These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21907455)

  • 21. Is bloodstream infection preventable among premature infants? A tale of two cities.
    Aly H; Herson V; Duncan A; Herr J; Bender J; Patel K; El-Mohandes AA
    Pediatrics; 2005 Jun; 115(6):1513-8. PubMed ID: 15930211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond the intensive care unit bundle: Implementation of a successful hospital-wide initiative to reduce central line-associated bloodstream infections.
    Klintworth G; Stafford J; O'Connor M; Leong T; Hamley L; Watson K; Kennon J; Bass P; Cheng AC; Worth LJ
    Am J Infect Control; 2014 Jun; 42(6):685-7. PubMed ID: 24837122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous placement of multiple central lines increases central line-associated bloodstream infection rates.
    Scheithauer S; Häfner H; Schröder J; Koch A; Krizanovic V; Nowicki K; Hilgers RD; Lemmen SW
    Am J Infect Control; 2013 Feb; 41(2):113-7. PubMed ID: 22906872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of tailored interventions in a statewide programme to reduce central line-associated bloodstream infections.
    Assis DB; Madalosso G; Padoveze MC; Lobo RD; Oliveira MS; Boszczowski Í; Singer JM; Levin AS
    J Hosp Infect; 2018 Nov; 100(3):e163-e168. PubMed ID: 29730142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central line-associated bloodstream infection in a trauma intensive care unit: impact of implementation of Society for Healthcare Epidemiology of America/Infectious Diseases Society of America practice guidelines.
    Mazi W; Begum Z; Abdulla D; Hesham A; Maghari S; Assiri A; Senok A
    Am J Infect Control; 2014 Aug; 42(8):865-7. PubMed ID: 25087138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a statewide collaborative to decrease NICU central line-associated bloodstream infections.
    Schulman J; Stricof RL; Stevens TP; Holzman IR; Shields EP; Angert RM; Wasserman-Hoff RS; Nafday SM; Saiman L; ;
    J Perinatol; 2009 Sep; 29(9):591-9. PubMed ID: 19262569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a multidisciplinary intervention on central line utilization in an acute care hospital.
    Faruqi A; Medefindt J; Dutta G; Philip SA; Tompkins D; Carey J
    Am J Infect Control; 2012 Aug; 40(6):e211-5. PubMed ID: 22418611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multitiered strategy of simulation training, kit consolidation, and electronic documentation is associated with a reduction in central line-associated bloodstream infections.
    Allen GB; Miller V; Nicholas C; Hess S; Cordes MK; Fortune JB; Blondin J; Ashikaga T; Ricci M
    Am J Infect Control; 2014 Jun; 42(6):643-8. PubMed ID: 24837115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rate and time to develop first central line-associated bloodstream infections when comparing open and closed infusion containers in a Brazilian Hospital.
    Vilins M; Blecher S; Silva MA; Rosenthal VD; Barker K; Salomao R
    Braz J Infect Dis; 2009 Oct; 13(5):335-40. PubMed ID: 20428631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current practices used for the prevention of central venous catheter-associated infection in hematopoietic stem cell transplantation recipients: a survey from the Infectious Diseases Working Party and Nurses' Group of EBMT.
    Snarski E; Mank A; Iacobelli S; Hoek J; Styczyński J; Babic A; Cesaro S; Johansson E
    Transpl Infect Dis; 2015 Aug; 17(4):558-65. PubMed ID: 25953418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
    Kontoyiannis DP; Marr KA; Park BJ; Alexander BD; Anaissie EJ; Walsh TJ; Ito J; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt LA; Kauffman CA; Knapp K; Lyon GM; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wannemuehler KA; Wingard JR; Chiller TM; Pappas PG
    Clin Infect Dis; 2010 Apr; 50(8):1091-100. PubMed ID: 20218877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of alcohol-impregnated port protectors and needleless neutral pressure connectors on central line-associated bloodstream infections and contamination of blood cultures in an inpatient oncology unit.
    Sweet MA; Cumpston A; Briggs F; Craig M; Hamadani M
    Am J Infect Control; 2012 Dec; 40(10):931-4. PubMed ID: 22575286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of a program to prevent central line-associated bloodstream infection in the zero tolerance era.
    Marra AR; Cal RG; Durão MS; Correa L; Guastelli LR; Moura DF; Edmond MB; Dos Santos OF
    Am J Infect Control; 2010 Aug; 38(6):434-9. PubMed ID: 20226570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of a central line maintenance care bundle in hospitalized pediatric oncology patients.
    Rinke ML; Chen AR; Bundy DG; Colantuoni E; Fratino L; Drucis KM; Panton SY; Kokoszka M; Budd AP; Milstone AM; Miller MR
    Pediatrics; 2012 Oct; 130(4):e996-e1004. PubMed ID: 22945408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central line-associated bloodstream infection prevention.
    Miller SE; Maragakis LL
    Curr Opin Infect Dis; 2012 Aug; 25(4):412-22. PubMed ID: 22766647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating central venous catheter care in a pediatric intensive care unit.
    Hatler C; Buckwald L; Salas-Allison Z; Murphy-Taylor C
    Am J Crit Care; 2009 Nov; 18(6):514-20; quiz 521. PubMed ID: 19880953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention and management of central line-associated bloodstream infections in hospital practice.
    Liang SY; Khair H; Durkin MJ; Marschall J
    Hosp Pract (1995); 2012 Feb; 40(1):106-18. PubMed ID: 22406886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a modified surveillance definition of central line-associated bloodstream infections for patients with hematologic malignancies.
    Digiorgio MJ; Fatica C; Oden M; Bolwell B; Sekeres M; Kalaycio M; Akins P; Shane C; Bako J; Gordon SM; Fraser TG
    Infect Control Hosp Epidemiol; 2012 Sep; 33(9):865-8. PubMed ID: 22869258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eradicating central line-associated bloodstream infections statewide: the Hawaii experience.
    Lin DM; Weeks K; Bauer L; Combes JR; George CT; Goeschel CA; Lubomski LH; Mathews SC; Sawyer MD; Thompson DA; Watson SR; Winters BD; Marsteller JA; Berenholtz SM; Pronovost PJ; Pham JC
    Am J Med Qual; 2012; 27(2):124-9. PubMed ID: 21918016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance Provinciale des Infections Nosocomiales (SPIN) Program: implementation of a mandatory surveillance program for central line-associated bloodstream infections.
    Fontela PS; Platt RW; Rocher I; Frenette C; Moore D; Fortin É; Buckeridge D; Pai M; Quach C
    Am J Infect Control; 2011 May; 39(4):329-35. PubMed ID: 21255873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.